Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 111.82M | 127.77M | 6.82M | 3.99M | -14.73M |
| Total Depreciation and Amortization | 4.60M | 4.69M | 4.66M | 4.63M | 4.43M |
| Total Amortization of Deferred Charges | 2.34M | 2.56M | 1.40M | 1.37M | 1.44M |
| Total Other Non-Cash Items | 20.36M | -10.36M | -53.56M | -56.10M | -50.16M |
| Change in Net Operating Assets | -13.19M | 32.97M | -25.10M | -20.02M | -21.07M |
| Cash from Operations | 125.92M | 157.64M | -65.78M | -66.14M | -80.09M |
| Capital Expenditure | -79.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 1.17M | 1.17M | 1.17M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 2.87M | 8.96M | 8.96M | 8.96M | 6.09M |
| Other Investing Activities | -- | -- | -- | -15.00M | -15.00M |
| Cash from Investing | 2.79M | 8.96M | 10.12M | -4.88M | -7.75M |
| Total Debt Issued | -- | -- | -- | 5.00M | 38.67M |
| Total Debt Repaid | -75.00K | -14.57M | -700.00K | -1.38M | -1.88M |
| Issuance of Common Stock | 3.89M | 4.27M | 3.96M | 4.22M | 10.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -14.34M | -14.45M | -265.00K | -265.00K | -265.00K |
| Total Dividends Paid | -- | -- | -- | 0.00 | 0.00 |
| Other Financing Activities | 4.00M | 22.66M | 74.45M | 89.96M | 38.18M |
| Cash from Financing | -6.52M | -2.09M | 77.44M | 97.54M | 85.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.19M | 164.50M | 21.79M | 26.52M | -2.66M |